China PharmaHub Corp. Share Price

China PharmaHub Corp. (PharmaHub), formerly World Wide Relics, Inc., is a global pharmaceutical HUB specializing in the identification, development and marketing of pharmaceutical and healthcare products. The Company is engaged in the commercialization of China preclinical and clinical stage compounds into the global pharmaceutical markets, as well as bringing the United States preclinical and clinical stage compounds into the China pharmaceutical market. The Company's pharmaceutical products will consist of products that meet the urgent medical needs. Its products include cancer, cardiology, cardiology/pulmonary, diabetes, neuroscience and osteoporosis. In China, PharmaHub has developed alliances and partnerships that advance its capacity to develop medicines at lower costs. In January 2011, the Company announced the formation of CPC NuLife, Inc., a subsidiary company.